Lawsonline™  Directory  Expert Witness  Oncology

Medical Advisors, Inc. Technical Network Consulting Service
Blue Bell, Pennsylvania
790 Penllyn Pike, Suite 105, 19422


Contact:  Elyce Klein
www.techmedexperts.com
215-653-7384 Or Toll Free 800-666-7045
info@techmedexperts.com
Technical Network Consulting Service
790 Penllyn Pike, Suite 105
Blue Bell, Pennsylvania 19422

Contact:  Elyce Klein
www.techmedexperts.com
215-653-7384 Or Toll Free 800-666-7045
info@techmedexperts.com
"Your Link to America's Most Qualified Experts ... and more!"
Information:  
Cardiology,  Forensic Psychiatry,  Forensic Psychology,  Head Injury,  Lab Testing and Analysis,  Laparoscopic Surgery,  Legal Medicine,  Linguistic Analysis,  Medical Devices,  Medical Malpractice,  Neurology,  Neuropsychiatry,  Neuropsychology,  Neurosurgery,  OBGYN,  Oncology,  Pharmaceuticals,  Pharmacology,  Psychiatric Malpractice,  Psychiatry,  Psychology,  Psychopharmacology,  Spinal Injury,  Urologists and Urology,  Vascular Surgery,  Wrongful Death, 


"Your Link to America's Most Qualified Experts ... and more!"

Ehrreich Consulting, Inc.
Fort Myers, Florida
15640 Greenock Lane, S.E., 33912


Contact:  Stewart J. Ehrreich Ph.D.,
www.regsolutions.com
239-561-2110 Or Toll Free
SEhrreich@aol.com
15640 Greenock Lane, S.E.
Fort Myers, Florida 33912

Contact:  Stewart J. Ehrreich Ph.D.,
www.regsolutions.com
239-561-2110
SEhrreich@aol.com
Dr. Stewart Ehrreich Ph.D. Is a former Deputy Division Director at the FDA, provides litigation support in Pharmacology, Pharmacokinetics, Biostatistics, Drug Chemistry, Clinical Trials and many other areas of expertise. He has acted in many Class Action suits and Patent Litigation cases as an Expert Witness. Dr. Ehrreich has given testimony both in court and in videotaped depositions, helped to prepare expert reports and legal briefs, and advised attorneys on risk management. For almost 25 years, Ehrreich Consulting, Inc. has participated in drug development by assisting pharmaceutical companies to get their drugs, medical devices, biologics and biotechnology approved by the FDA.
Information:  
Biotechnology,  Cardiology,  Chemistry,  Dermatology,  Emergency Medicine,  Medical Devices,  Oncology,  Pharmaceuticals,  Pharmacology,  Psychopharmacology,  Sports Medicine,  Toxic Tort,  Toxicology, 


Dr. Stewart Ehrreich Ph.D. Is a former Deputy Division Director at the FDA, provides litigation support in Pharmacology, Pharmacokinetics, Biostatistics, Drug Chemistry, Clinical Trials and many other areas of expertise. He has acted in many Class Action suits and Patent Litigation cases as an Expert Witness. Dr. Ehrreich has given testimony both in court and in videotaped depositions, helped to prepare expert reports and legal briefs, and advised attorneys on risk management. For almost 25 years, Ehrreich Consulting, Inc. has participated in drug development by assisting pharmaceutical companies to get their drugs, medical devices, biologics and biotechnology approved by the FDA.

Private Consultant in Chemical Toxicology and Chemical Carcinogenesis
Altadena, California
1009 E. Mendocino St, 91001


Contact:  Joseph Richard Landolph, Jr, Ph.D.
Private Consultant in Chemical Toxicology and Chemical Carcinogenesis WEBSITE
323-224-7781 Or Toll Free
joseph.landolph@med.usc.edu
1009 E. Mendocino St
Altadena, California 91001

Contact:  Joseph Richard Landolph, Jr, Ph.D.
Private Consultant in Chemical Toxicology and Chemical Carcinogenesis WEBSITE
323-224-7781
joseph.landolph@med.usc.edu
Cell: 626-993-4397. Joseph R. Landolph, Jr., Ph. D., received B. S. in Chem. from Drexel Univ., Phila., Pa., l971, and Ph. D. in Chemistry from Univ. of Calif. Berkeley, l976, where he studied BaP metabolism and cytotoxicity in mouse liver epithelial/fibroblastic cells. He performed postdoctoral study in chemical carcinogenesis (l977-1980) at the University of Southern California (USC). He was appointed Asst. Prof. of Microbiology/Pathology in l982, and is now Assoc. Prof. of Molecular Microbiology and Immunology/Pathology and Member, USC Cancer Center, Keck School of Medicine, USC. His research interests include carcinogenicity of Ni/Cr compounds, activation of oncogenes/inactivation of tumor suppressor genes, and de-regulation of gene expression, in Ni/Cr carcinogenesis. He is an expert in chemically induced mutation/neoplastic transformation of mammalian cells. He authored 61 scientific publications, gave 190 invited scientific lectures, and trained 20 M. S. students, 11 Ph. D. students and 30 postdoctoral fellows. He reviewed research grants for the US EPA, NIEHS, Chem. Pathol./AlTx-4 Study Sections, NIH; served as a member of Carcinogen Ident. Comm., Calif. EPA (1994-Present); Sci. Rev. Panel for Toxic Air Contaminants, Calif. Air Resour. Brd. (2003-2011); Drinking Water (2003-2009) and Human Health Res. (2003) Committees of US EPA’s Science Advisory Board; NAS Panel on U. S. EPA’s PCE Risk Assessment (2009-2010). He received the Merck Award in Chemistry (Drexel Univ.); an American Cancer Society Postdoctoral Fellowship; an Edmundson Teaching Award (Dept. Path., USC); and a Traveling Lectureship Award (Soc. Tox.). He has held research grants from EPA, NCI, NIEHS. He serves as a part-time Consultant/Expert Witness in Chemical Toxicology and Chemical Carcinogenesis.
Information:  
Hazardous Materials,  Oncology,  Toxic Exposures,  Toxic Tort,  Toxicology, 


Cell: 626-993-4397. Joseph R. Landolph, Jr., Ph. D., received B. S. in Chem. from Drexel Univ., Phila., Pa., l971, and Ph. D. in Chemistry from Univ. of Calif. Berkeley, l976, where he studied BaP metabolism and cytotoxicity in mouse liver epithelial/fibroblastic cells. He performed postdoctoral study in chemical carcinogenesis (l977-1980) at the University of Southern California (USC). He was appointed Asst. Prof. of Microbiology/Pathology in l982, and is now Assoc. Prof. of Molecular Microbiology and Immunology/Pathology and Member, USC Cancer Center, Keck School of Medicine, USC. His research interests include carcinogenicity of Ni/Cr compounds, activation of oncogenes/inactivation of tumor suppressor genes, and de-regulation of gene expression, in Ni/Cr carcinogenesis. He is an expert in chemically induced mutation/neoplastic transformation of mammalian cells. He authored 61 scientific publications, gave 190 invited scientific lectures, and trained 20 M. S. students, 11 Ph. D. students and 30 postdoctoral fellows. He reviewed research grants for the US EPA, NIEHS, Chem. Pathol./AlTx-4 Study Sections, NIH; served as a member of Carcinogen Ident. Comm., Calif. EPA (1994-Present); Sci. Rev. Panel for Toxic Air Contaminants, Calif. Air Resour. Brd. (2003-2011); Drinking Water (2003-2009) and Human Health Res. (2003) Committees of US EPA’s Science Advisory Board; NAS Panel on U. S. EPA’s PCE Risk Assessment (2009-2010). He received the Merck Award in Chemistry (Drexel Univ.); an American Cancer Society Postdoctoral Fellowship; an Edmundson Teaching Award (Dept. Path., USC); and a Traveling Lectureship Award (Soc. Tox.). He has held research grants from EPA, NCI, NIEHS. He serves as a part-time Consultant/Expert Witness in Chemical Toxicology and Chemical Carcinogenesis.

Western Oncology & Hematology Consulting Services
Laramie, Wyoming
112 Satanka Road, 82070


Contact:  Clinton F Merrill, MD
www.westernoncology.com
308-225-3954 Or Toll Free
clinton.merrill@hotmail.com
112 Satanka Road
Laramie, Wyoming 82070

Contact:  Clinton F Merrill, MD
www.westernoncology.com
308-225-3954
clinton.merrill@hotmail.com
Experienced in the diagnosis and treatment of all solid tumors as well as the full range of hematologic malignancies. Special expertise in benign hematology including: anemias, low blood cell counts, iron overload disorders, and bleeding and clotting disorders. I take pride in providing thorough record review, meticulously researched reports reflecting unbiased opinions, and excellent communication skills with the ability to make the complex understandable.
Information:  
Hematology,  Internal Medicine,  Oncology, 


Experienced in the diagnosis and treatment of all solid tumors as well as the full range of hematologic malignancies. Special expertise in benign hematology including: anemias, low blood cell counts, iron overload disorders, and bleeding and clotting disorders. I take pride in providing thorough record review, meticulously researched reports reflecting unbiased opinions, and excellent communication skills with the ability to make the complex understandable.

Major Medical Productions
Bryn Mawr, Pennsylvania
127 Locust Grove Rd., 19010


Contact:  Nancy M. Major MD
Major Medical Productions WEBSITE
267-254-5412 Or Toll Free
nancy.major1@gmail.com
127 Locust Grove Rd.
Bryn Mawr, Pennsylvania 19010

Contact:  Nancy M. Major MD
Major Medical Productions WEBSITE
267-254-5412
nancy.major1@gmail.com
As a musculoskeletal radiologist in practice since 1997, Dr. Nancy Major’s career has largely been in academic radiology (Duke and the University of Pennsylvania) where she devoted a great deal of time to education of students, residents and practicing radiologists. It was during this experience that Dr. Major honed the skills necessary to be an effective communicator. More recently she has been working in the private sector. Dr. Major has been doing expert witness testimony for plaintiff as well as defendants. She has also functioned as a consultant when necessary. Her assistance has been used in hundreds of cases in over 15 states and includes depositions as well as court appearances. Dr. Major's abilities to communicate with counsel, opposing counsel and juries is due to the experience she has gained through her professional career as well as the years of expert witness opportunities.
Information:  
Oncology,  Orthopedics,  Radiology,  Spinal Injury,  Sports Medicine, 


As a musculoskeletal radiologist in practice since 1997, Dr. Nancy Major’s career has largely been in academic radiology (Duke and the University of Pennsylvania) where she devoted a great deal of time to education of students, residents and practicing radiologists. It was during this experience that Dr. Major honed the skills necessary to be an effective communicator. More recently she has been working in the private sector. Dr. Major has been doing expert witness testimony for plaintiff as well as defendants. She has also functioned as a consultant when necessary. Her assistance has been used in hundreds of cases in over 15 states and includes depositions as well as court appearances. Dr. Major's abilities to communicate with counsel, opposing counsel and juries is due to the experience she has gained through her professional career as well as the years of expert witness opportunities.

Oncology Consulting Services, LLC
Syracuse, Indiana
741 East Northshore Drive, 46567


Contact:  Kenneth L Pennington, MD
www.oncolaw.com
574-355-3333 Or Toll Free
drp@oncolaw.com
741 East Northshore Drive
Syracuse, Indiana 46567

Contact:  Kenneth L Pennington, MD
www.oncolaw.com
574-355-3333
drp@oncolaw.com
Information:  
Oncology, 



Richard G. Pestell, MD, PhD, FRACP, FACP, MBA
Wynnewood, Pennsylvania
100 East Lancaster Avenue Suite 222, 19096


Contact:  Richard G. Pestell, MD, PhD, FRACP, FACP, MBA
Richard G. Pestell, MD, PhD, FRACP, FACP, MBA
267-402-0545 Or Toll Free
richard.pestell@gmail.com
100 East Lancaster Avenue Suite 222
Wynnewood, Pennsylvania 19096

Contact:  Richard G. Pestell, MD, PhD, FRACP, FACP, MBA
Richard G. Pestell, MD, PhD, FRACP, FACP, MBA
267-402-0545
richard.pestell@gmail.com
Information:  
Intellectual Properties,  Internal Medicine,  Medical Malpractice,  Oncology,  Patents,